Lattice SVP sells 4,279 shares under 10b5-1
SVP of R&D Pravin Desale reported pre-planned open-market sales totaling 4,279 LSCC shares under a Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
LATTICE SEMICONDUCTOR CORP (LSCC) reported that Pravin Desale, SVP, R&D, sold a total of 4,279 shares of common stock on September 15, 2026 in three open-market transactions: 1,700 shares at a weighted average price of $105.0018, 2,379 shares at $105.9742, and 200 shares at $106.7700. Each trade was executed in multiple lots within stated price ranges, and all transactions were conducted under an approved Rule 10b5-1 trading plan adopted or modified on February 18, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 4,279 shares
Net Sell
3 txns
Insider
Desale Pravin
Role
SVP, R&D
Sold
4,279 shs ($452K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,700 | $105.0018 | $179K |
| Sale | Common Stock F1, F3 | 2,379 | $105.9742 | $252K |
| Sale | Common Stock F1, F4 | 200 | $106.77 | $21K |
Holdings After Transaction:
Common Stock — 69,177 shares (Direct)
Footnotes (4)
- F1. The transaction indicated was conducted under an approved 10b5-1 Plan, adoption modification date of referenced 10b5-1(c) plan is: 02-18-2026.
- F2. This transaction was executed in multiple trades at prices ranging from $104.5600 to $105.5000. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F3. This transaction was executed in multiple trades at prices ranging from $105.5700 to $106.4200. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F4. This transaction was executed in multiple trades at prices ranging from $106.5900 to $106.9500. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Key Figures
Shares sold (total): 4,279 shares
First tranche sold: 1,700 shares at $105.0018 per share
Second tranche sold: 2,379 shares at $105.9742 per share
+2 more
5 metrics
Shares sold (total)
4,279 shares
Common stock sales by Pravin Desale on September 15, 2026
First tranche sold
1,700 shares at $105.0018 per share
Weighted average price for one sale tranche on September 15, 2026
Second tranche sold
2,379 shares at $105.9742 per share
Weighted average price for one sale tranche on September 15, 2026
Third tranche sold
200 shares at $106.7700 per share
Weighted average price for one sale tranche on September 15, 2026
Rule 10b5-1 plan adoption/modification date
February 18, 2026
Plan governing the reported insider sales
Key Terms
Rule 10b5-1 Plan, weighted average sale price, open market or private transaction
3 terms
Rule 10b5-1 Plan regulatory
"The transaction indicated was conducted under an approved 10b5-1 Plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"The price reported above reflects the weighted average sale price"
open market or private transaction financial
"Sale in open market or private transaction"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LSCC report for Pravin Desale on this Form 4?
The filing reports that Pravin Desale, SVP, R&D of LATTICE SEMICONDUCTOR CORP, sold 4,279 shares of common stock in open-market transactions on September 15, 2026.
Were the LSCC insider sales made under a Rule 10b5-1 trading plan?
Yes. The filing states the transactions were conducted under an approved Rule 10b5-1 Plan, with an adoption or modification date of February 18, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.